Avidian Wealth Enterprises’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,008
| Closed | -$234K | – | 503 |
|
|
2024
Q2 | $234K | Buy |
1,008
+78
| +8% | +$18.1K | 0.01% | 439 |
|
|
2024
Q1 | $201K | Sell |
930
-457
| -33% | -$98.5K | 0.01% | 424 |
|
|
2023
Q4 | $359K | Buy |
1,387
+75
| +6% | +$19.4K | 0.02% | 311 |
|
|
2023
Q3 | $337K | Sell |
1,312
-2,092
| -61% | -$538K | 0.02% | 311 |
|
|
2023
Q2 | $970K | Buy |
3,404
+41
| +1% | +$11.7K | 0.06% | 181 |
|
|
2023
Q1 | $935K | Sell |
3,363
-29
| -0.9% | -$8.06K | 0.05% | 208 |
|
|
2022
Q4 | $939K | Sell |
3,392
-528
| -13% | -$146K | 0.06% | 186 |
|
|
2022
Q3 | $1.05M | Buy |
3,920
+937
| +31% | +$250K | 0.08% | 143 |
|
|
2022
Q2 | $608K | Buy |
2,983
+358
| +14% | +$73K | 0.04% | 236 |
|
|
2022
Q1 | $553K | Buy |
2,625
+660
| +34% | +$139K | 0.03% | 273 |
|
|
2021
Q4 | $471K | Buy |
1,965
+17
| +0.9% | +$4.08K | 0.03% | 306 |
|
|
2021
Q3 | $551K | Buy |
1,948
+392
| +25% | +$111K | 0.04% | 199 |
|
|
2021
Q2 | $539K | Buy |
1,556
+155
| +11% | +$53.7K | 0.04% | 207 |
|
|
2021
Q1 | $392K | Buy |
1,401
+86
| +7% | +$24.1K | 0.03% | 244 |
|
|
2020
Q4 | $322K | Buy |
+1,315
| New | +$322K | 0.03% | 245 |
|